Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FREEZE-B: Chest Tube-Delivered Bupivacaine for Postoperative Pain After Cardiac Surgery
NCT07643506Phase 1Not yet recruiting
- Sponsor
- University of Calgary
- Start
- Jun 2026
- Primary completion
- Jun 2027
01
Overview
Phase 1, randomised, double-blind trial in postoperative pain comparing 0.9% Saline (Placebo) with 0.5% Bupivacaine group (2 arms). Primary endpoint: Pain intensity numeric rating scale (NRS) at 240 months. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07643506.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07643506.